 |
Listening In (With Permission): Conversations About Today's Pressing Health Care TopicsListen in as Catalyst for Payment Reform dials up Author: Catalyst for Payment Reform
Listen in as Catalyst for Payment Reform dials up health care leaders to discuss some of the biggest questions we face today. Language: en Genres: Health & Fitness Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Episode 140: Shawn Gremminger on the Hidden Costs of the 340B Drug Pricing Program
Tuesday, 20 May, 2025
In this episode of Listening In (With Permission), Shawn Gremminger, President and CEO of the National Alliance of Healthcare Purchaser Coalitions, joins Andréa Caballero of Catalyst for Payment Reform to dive into a pressing but often overlooked issue: the impact of the 340B Drug Pricing Program on pharmacy costs for employers and healthcare purchasers. The 340B program, originally intended to support safety-net hospitals and community health centers, has expanded drastically over the years. Today, it's the second-largest drug purchasing program in the U.S., with an explosive $65 billion price tag. But what does this mean for employers and employees in the commercial market?
